1. Home
  2. SSL vs ICUI Comparison

SSL vs ICUI Comparison

Compare SSL & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sasol Ltd.

SSL

Sasol Ltd.

HOLD

Current Price

$6.17

Market Cap

3.8B

Sector

Energy

ML Signal

HOLD

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$147.75

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSL
ICUI
Founded
1950
1984
Country
South Africa
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.2B
IPO Year
N/A
1992

Fundamental Metrics

Financial Performance
Metric
SSL
ICUI
Price
$6.17
$147.75
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$183.60
AVG Volume (30 Days)
823.7K
236.9K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.59
N/A
Revenue
$14,028,282,389.00
$2,320,363,000.00
Revenue This Year
$1.17
N/A
Revenue Next Year
$6.50
N/A
P/E Ratio
$10.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.78
$107.00
52 Week High
$7.39
$175.51

Technical Indicators

Market Signals
Indicator
SSL
ICUI
Relative Strength Index (RSI) 43.95 63.16
Support Level $5.97 $141.10
Resistance Level $6.43 $148.95
Average True Range (ATR) 0.12 3.94
MACD -0.04 -0.36
Stochastic Oscillator 33.60 58.68

Price Performance

Historical Comparison
SSL
ICUI

About SSL Sasol Ltd.

Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main businesses: the Southern Africa Energy & Chemicals business and the International Chemical business. It generates maximum revenue from the Southern Africa Energy & Chemicals business, which operates integrated value chains with feedstock sourced from the Mining and Gas operating segments. Geographically, the company generates the majority of its revenue from South Africa.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Share on Social Networks: